These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epstein-Barr virus (EBV) genotypes among human immunodeficiency virus (HIV)-related B-cell lymphomas and B-cell post-transplant lymphoproliferative disorders (B-PTLD)--late-onset lymphomas, especially in the HIV setting, are associated with type-B-EBV. Ibrahim HA; Menasce LP; Pomplun S; Burke M; Bower M; Naresh KN Eur J Haematol; 2010 Sep; 85(3):227-30. PubMed ID: 20408873 [TBL] [Abstract][Full Text] [Related]
4. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Taylor AL; Marcus R; Bradley JA Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109 [TBL] [Abstract][Full Text] [Related]
7. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438 [TBL] [Abstract][Full Text] [Related]
8. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094 [TBL] [Abstract][Full Text] [Related]
9. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab. Loomis R; Carbone R; Reiss M; Lacy J Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients. Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912 [TBL] [Abstract][Full Text] [Related]
11. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Lim WH; Russ GR; Coates PT Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577 [TBL] [Abstract][Full Text] [Related]
12. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Johnson LR; Nalesnik MA; Swerdlow SH Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518 [TBL] [Abstract][Full Text] [Related]
13. Post-transplant lymphoproliferative disorder: a review. Loren AW; Porter DL; Stadtmauer EA; Tsai DE Bone Marrow Transplant; 2003 Feb; 31(3):145-55. PubMed ID: 12621474 [TBL] [Abstract][Full Text] [Related]